What effect does Celebrex have on the blood?
Anemia is sometimes seen in patients receiving Celebrex. In controlled clinical trials the incidence of anemia was 0.6% with Celebrex and 0.4% with placebo. Patients on long-term treatment with Celebrex should have their hemoglobin or hematocrit checked if they exhibit any signs or symptoms of anemia or blood loss. Celebrex does not generally affect platelet counts, prothrombin time (PT), or partial thromboplastin time (PTT), and does not appear to inhibit platelet aggregation at indicated dosages.
Anemia is sometimes seen in patients receiving Celebrex . In controlled clinical trials the incidence of anemia was 0.6% with Celebrex and 0.4% with placebo. Patients on long-term treatment with Celebrex should have their hemoglobin or hematocrit checked if they exhibit any signs or symptoms of anemia or blood loss. Celebrex does not generally affect platelet counts, prothrombin time (PT), or partial thromboplastin time (PTT), and does not appear to inhibit platelet aggregation at indicated dosages.
